• Supporting rare disease patient advocacy with epidemiological insights

    Awareness of the vast impact of rare diseases, which affect approximately 300 million people globally (1), has significantly increased over the years, leading to increased funding and investment in rare disease research and therapy development.   Although more than half of the novel drug approvals by the FDA’s Center for Drug Evaluation and Research last […]